Opioid use disorder

J Strang, ND Volkow, L Degenhardt… - Nature reviews Disease …, 2020 - nature.com
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by
activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that …

Retention in medication-assisted treatment for opiate dependence: a systematic review

C Timko, NR Schultz, MA Cucciare… - Journal of addictive …, 2016 - Taylor & Francis
Retention in medication-assisted treatment among opiate-dependent patients is associated
with better outcomes. This systematic review (55 articles, 2010–2014) found wide variability …

Global patterns of opioid use and dependence: harms to populations, interventions, and future action

L Degenhardt, J Grebely, J Stone, M Hickman… - The Lancet, 2019 - thelancet.com
We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address …

The rise of multiple imputation: a review of the reporting and implementation of the method in medical research

P Hayati Rezvan, KJ Lee, JA Simpson - BMC medical research …, 2015 - Springer
Background Missing data are common in medical research, which can lead to a loss in
statistical power and potentially biased results if not handled appropriately. Multiple …

Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction

J Strang, T Groshkova, A Uchtenhagen… - The British Journal of …, 2015 - cambridge.org
BackgroundSupervised injectable heroin (SIH) treatment has emerged over the past 15
years as an intensive treatment for entrenched heroin users who have not responded to …

Addiction and brain reward and antireward pathways

EL Gardner - Chronic Pain and Addiction, 2011 - karger.com
Addictive drugs have in common that they are voluntarily self-administered by laboratory
animals (usually avidly), and that they enhance the functioning of the reward circuitry of the …

Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial

E Oviedo-Joekes, D Guh, S Brissette… - JAMA …, 2016 - jamanetwork.com
Importance Diacetylmorphine hydrochloride (the active ingredient in heroin), delivered
under supervision, is effective for the treatment of severe opioid use disorder. However …

Drug policy and the public good

T Babor - 2010 - books.google.com
Drug use represents a significant burden to public health through disease, disability and
social problems, and policy makers are becoming increasingly interested in how to develop …

Drug policy and the public good: evidence for effective interventions

J Strang, T Babor, J Caulkins, B Fischer, D Foxcroft… - The Lancet, 2012 - thelancet.com
Debates about which policy initiatives can prevent or reduce the damage that illicit drugs
cause to the public good are rarely informed by scientific evidence. Fortunately, evidence …

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity …

AR Lingford-Hughes, S Welch… - Journal of …, 2012 - journals.sagepub.com
The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …